Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

MSD Australia & New ZealandMSD Australia & New Zealand
VS
Glenmark PharmaceuticalsGlenmark Pharmaceuticals
MSD Australia & New Zealand

MSD Australia & New Zealand

Level 1, 26 Talavera Road, Macquarie Park, NSW, 2113, AU

Last Update: 10/03/2026

View Profile
756/1000Fair

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:538
Subsidiaries:39
12-month incidents
0
Known data breaches
0
Attack type number
0
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099

Last Update: 12/09/2026

View Profile
650/1000Weak

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,777
Subsidiaries:0
12-month incidents
1
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
MSD Australia & New Zealand

MSD Australia & New Zealand

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Australia & New Zealand in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Glenmark Pharmaceuticals has 0.99% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - MSD Australia & New Zealand (X = Date, Y = Severity)

MSD Australia & New Zealand cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
MSD Australia & New Zealand

MSD Australia & New Zealand

Incidents
No explicit notable incidents reported.
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Incidents
🔒 Incident : Ransomware
KOPGLE1777473227

FAQ

Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has experienced at least one data breach ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one holds the most compliance certifications ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has the most subsidiaries ?
Between MSD Australia & New Zealand company and Glenmark Pharmaceuticals company, which one has the largest number of employees ?
Between MSD Australia & New Zealand and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between MSD Australia & New Zealand and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - MSD Australia & New Zealand or Glenmark Pharmaceuticals ?
Which company is PCI DSS compliant - MSD Australia & New Zealand or Glenmark Pharmaceuticals ?
Between MSD Australia & New Zealand and Glenmark Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between MSD Australia & New Zealand and Glenmark Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-103761
SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a memory exhaustion vulnerability in TransferMetadata::receivePeerNotify that allows unauthenticated attackers to grow process memory without limit. Attackers can repeatedly send notify frames up to 1 MB to the handshake RPC port, filling the uncapped notifys vector until the out-of-memory killer terminates the engine.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-103760
SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a denial of service vulnerability that allows unauthenticated remote attackers to block the handshake daemon by never reading replies. Attackers can send a Metadata request to the handshake RPC port and stall SocketHandShakePlugin's single listener thread in writeFully(), breaking all subsequent handshakes, metadata fetches, notify and probe requests.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 5.9)
CVSS3
Base Score: 5.9
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.2
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.2
CVE-2025-71427
SUMMARY

Office-PowerPoint-MCP-Server through 2.0.7 contains a path traversal vulnerability that allows MCP callers to write and read files outside the working directory by supplying absolute paths or ../ sequences. Attackers can steer an AI agent via prompt injection to abuse save_presentation, open_presentation, or manage_image output_path to overwrite any server-writable file or load external files.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-86344
SUMMARY

A flaw was found in 389-ds-base. An unauthenticated remote attacker can send a complete LDAP operation followed by the first bytes of an incomplete LDAPMessage on the same connection, causing the server to hand that connection to a second worker thread before the first worker's result is flushed. The second worker blocks until nsslapd-ioblocktimeout while holding the connection mutex, preventing delivery of the completed operation's result. Repeating this across a small number of connections proportional to the configured worker-thread pool size exhausts the entire pool under default configuration, denying service to all clients (anonymous and authenticated, plaintext and TLS) for as long as the attacker maintains the connections.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-71454
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in CWE-79 - Cross-site Scripting CAPEC-63 allows Cross-Site Scripting (XSS). This issue affects CAPEC-63: before 3.0b63.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA